Skip to main content
Top
Published in: Diabetologia 12/2018

Open Access 01-12-2018 | Article

Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study

Authors: Thenmalar Vadiveloo, William Jeffcoate, Peter T. Donnan, Helen C. Colhoun, Stuart McGurnaghan, Sarah Wild, Rory McCrimmon, Graham P. Leese, on behalf of the Scottish Diabetes Research Network Epidemiology Group

Published in: Diabetologia | Issue 12/2018

Login to get access

Abstract

Aims/hypothesis

Our aim was to investigate amputation-free survival in people at high risk for foot ulceration in diabetes (‘high-risk foot’), and to compare different subcategories of high-risk foot.

Methods

Overall, 17,353 people with diabetes and high-risk foot from January 2008 to December 2011 were identified from the Scotland-wide diabetes register (Scottish Care Information-Diabetes: N = 247,278). Participants were followed-up for up to 2 years from baseline and were categorised into three groups: (1) those with no previous ulcer, (2) those with an active ulcer or (3) those with a healed previous ulcer. Participants with prior minor or major amputation were excluded. Accelerated failure time models were used to compare amputation-free survival up to 2 years between the three exposure groups.

Results

The 2 year amputation-free survival rate in all people with diabetes with high-risk foot was 84.5%. In this study group, 270 people (10.0%) had an amputation and 2424 (90.0%) died during the 2 year follow-up period. People who had active and healed previous ulcers at baseline had significantly lower 2 year amputation-free survival compared with those who had no previous ulcer (both p < 0.0001). The percentage of people who died within 2 years for those with healed ulcer, active ulcer or no baseline ulcer was 22.8%, 16% and 12.1%, respectively.

Conclusions/interpretation

In people judged to be at high risk of foot ulceration, the risk of death was up to nine times the risk of amputation. Death rates were higher for people with diabetes who had healed ulcers than for those with active ulcers. However, people with active ulcers had the highest risk of amputation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Armstrong DG, Boulton AJM, Bus SA (2017) Diabetic foot ulcers and their recurrence. N Engl J Med 376:2367–2375CrossRef Armstrong DG, Boulton AJM, Bus SA (2017) Diabetic foot ulcers and their recurrence. N Engl J Med 376:2367–2375CrossRef
2.
go back to reference Wu SC, Driver VR, Wrobel JS, Armstrong DG (2007) Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 3:65–76PubMedPubMedCentral Wu SC, Driver VR, Wrobel JS, Armstrong DG (2007) Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 3:65–76PubMedPubMedCentral
3.
go back to reference Hoffstad O, Mitra N, Walsh J, Margolis DJ (2015) Diabetes, lower-extremity amputation, and death. Diabetes Care 38:1852–1857CrossRef Hoffstad O, Mitra N, Walsh J, Margolis DJ (2015) Diabetes, lower-extremity amputation, and death. Diabetes Care 38:1852–1857CrossRef
4.
go back to reference Kennon B, Leese GP, Cochrane L et al (2012) Reduced incidence of lower extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care 35:2588–2590CrossRef Kennon B, Leese GP, Cochrane L et al (2012) Reduced incidence of lower extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care 35:2588–2590CrossRef
5.
go back to reference Holman N, Young RJ, Jeffcoate WJ (2012) Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia 55:1919–1925CrossRef Holman N, Young RJ, Jeffcoate WJ (2012) Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia 55:1919–1925CrossRef
6.
go back to reference Lavery LA, Lavery DC, Quebedaux-Farnham TL (1995) Increased foot pressures after great toe amputation in diabetes. Diabetes Care 18:1460–1462CrossRef Lavery LA, Lavery DC, Quebedaux-Farnham TL (1995) Increased foot pressures after great toe amputation in diabetes. Diabetes Care 18:1460–1462CrossRef
7.
go back to reference Schirr-Bonnans S, Costa N, Derumeaux-Burel H et al (2017) Cost of diabetic eye, renal and foot complications: a methodological review. Eur J Health Econ 18:293–312CrossRef Schirr-Bonnans S, Costa N, Derumeaux-Burel H et al (2017) Cost of diabetic eye, renal and foot complications: a methodological review. Eur J Health Econ 18:293–312CrossRef
8.
go back to reference Jeffcoate WJ, Harding KG (2003) Diabetic foot ulcers. Lancet 361:1545–1551CrossRef Jeffcoate WJ, Harding KG (2003) Diabetic foot ulcers. Lancet 361:1545–1551CrossRef
9.
go back to reference Winkley K, Stahl D, Chalder T, Edmonds ME, Ismail K (2007) Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complicat 21:341–349CrossRef Winkley K, Stahl D, Chalder T, Edmonds ME, Ismail K (2007) Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complicat 21:341–349CrossRef
10.
go back to reference Van Olmen J, Marie KG, Christian D et al (2015) Content, participants and outcomes of three diabetes care programmes in three low and middle income countries. Prim Care Diabetes 9:196–202CrossRef Van Olmen J, Marie KG, Christian D et al (2015) Content, participants and outcomes of three diabetes care programmes in three low and middle income countries. Prim Care Diabetes 9:196–202CrossRef
11.
go back to reference Quddus MA, Uddin MJ (2013) Evaluation of foot ulcers in diabetic patients. Mymensingh Med J 22:527–532PubMed Quddus MA, Uddin MJ (2013) Evaluation of foot ulcers in diabetic patients. Mymensingh Med J 22:527–532PubMed
12.
go back to reference Parisi MCR, Moura Neto A, Menezes FH et al (2016) Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr 8:25CrossRef Parisi MCR, Moura Neto A, Menezes FH et al (2016) Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr 8:25CrossRef
13.
go back to reference Markowitz JS, Gutterman EM, Magee G, Margolis DJ (2006) Risk of amputation in patients with diabetic foot ulcers: a claims-based study. Wound Repair Regen 14:11–17CrossRef Markowitz JS, Gutterman EM, Magee G, Margolis DJ (2006) Risk of amputation in patients with diabetic foot ulcers: a claims-based study. Wound Repair Regen 14:11–17CrossRef
14.
go back to reference Carlson T, Reed JF (2003) A case-control study of the risk factors for toe amputation in a diabetic population. Int J Low Extrem Wounds 2:19–21CrossRef Carlson T, Reed JF (2003) A case-control study of the risk factors for toe amputation in a diabetic population. Int J Low Extrem Wounds 2:19–21CrossRef
15.
go back to reference Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M (2001) Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes. Diabetologia 44(Suppl 2):S65–S71CrossRef Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M (2001) Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes. Diabetologia 44(Suppl 2):S65–S71CrossRef
16.
go back to reference Won SH, Chung CY, Park MS et al (2014) Risk factors associated with amputation-free survival in patient with diabetic foot ulcers. Yonsei Med J 55:1373–1378CrossRef Won SH, Chung CY, Park MS et al (2014) Risk factors associated with amputation-free survival in patient with diabetic foot ulcers. Yonsei Med J 55:1373–1378CrossRef
17.
go back to reference Leese GP, Reid F, Green V et al (2006) Stratification of foot ulcer risk in patients with diabetes: a population-based study. Int J Clin Pract 60:541–545CrossRef Leese GP, Reid F, Green V et al (2006) Stratification of foot ulcer risk in patients with diabetes: a population-based study. Int J Clin Pract 60:541–545CrossRef
18.
go back to reference Leese GP, Schofield CJ, McMurray B et al (2007) Scottish foot ulcer risk score predicts healing in a regional specialist foot clinic. Diabetes Care 30:2064–2069CrossRef Leese GP, Schofield CJ, McMurray B et al (2007) Scottish foot ulcer risk score predicts healing in a regional specialist foot clinic. Diabetes Care 30:2064–2069CrossRef
20.
go back to reference Peters EJ, Lavery LA (2001) Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 24:1442–1447CrossRef Peters EJ, Lavery LA (2001) Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 24:1442–1447CrossRef
21.
go back to reference Boyko EJ, Ahoroni JH, Cohen V, Nelson KM, Heagerty PJ (2006) Prediction of diabetic foot ulcer occurrence using commonly available clinical information. Diabetes Care 29:1202–1207CrossRef Boyko EJ, Ahoroni JH, Cohen V, Nelson KM, Heagerty PJ (2006) Prediction of diabetic foot ulcer occurrence using commonly available clinical information. Diabetes Care 29:1202–1207CrossRef
22.
go back to reference Abbott CA, Carrington AL, Ashe H et al (2002) The North West Diabetes Care Foot study: incidence of, risk factors for, new diabetic foot ulceration in a community-based cohort. Diabet Med 19:377–384CrossRef Abbott CA, Carrington AL, Ashe H et al (2002) The North West Diabetes Care Foot study: incidence of, risk factors for, new diabetic foot ulceration in a community-based cohort. Diabet Med 19:377–384CrossRef
23.
go back to reference Leese GP, Cochrane L, Mackie AD, Stang D, Brown K, Green V (2011) Measuring the accuracy of different ways to identify the ‘at risk’ foot in routine clinical practice. Diabet Med 28:747–754CrossRef Leese GP, Cochrane L, Mackie AD, Stang D, Brown K, Green V (2011) Measuring the accuracy of different ways to identify the ‘at risk’ foot in routine clinical practice. Diabet Med 28:747–754CrossRef
24.
go back to reference Game F (2016) Classification of diabetic foot ulcers. Diabetes Metab Res Rev 32(Suppl 1):186–194CrossRef Game F (2016) Classification of diabetic foot ulcers. Diabetes Metab Res Rev 32(Suppl 1):186–194CrossRef
25.
go back to reference Gershater MA, Löndahl M, Nyberg P et al (2009) Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 52:398–407CrossRef Gershater MA, Löndahl M, Nyberg P et al (2009) Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 52:398–407CrossRef
26.
go back to reference Pound N, Chipchase S, Treece K, Game F, Jeffcoate W (2005) Ulcer free survival following management of foot ulcers in diabetes. Diabet Med 22:1306–1309CrossRef Pound N, Chipchase S, Treece K, Game F, Jeffcoate W (2005) Ulcer free survival following management of foot ulcers in diabetes. Diabet Med 22:1306–1309CrossRef
27.
go back to reference Jeffcoate WJ, Chipchase SY, Ince P, Game FL (2006) Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 29:1784–1787CrossRef Jeffcoate WJ, Chipchase SY, Ince P, Game FL (2006) Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 29:1784–1787CrossRef
28.
go back to reference Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJM (2001) A comparison of two diabetic foot ulcer classification systems. Diabetes Care 24:84–88CrossRef Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJM (2001) A comparison of two diabetic foot ulcer classification systems. Diabetes Care 24:84–88CrossRef
29.
go back to reference Young MJ, McCardle JE, Randall LE, Barclay JI (2008) Improved survival of diabetic foot ulcer patients 1995-2008: possible impact of aggressive cardiovascular risk management. Diabetes Care 31:2143–2147CrossRef Young MJ, McCardle JE, Randall LE, Barclay JI (2008) Improved survival of diabetic foot ulcer patients 1995-2008: possible impact of aggressive cardiovascular risk management. Diabetes Care 31:2143–2147CrossRef
30.
go back to reference Gurnley JK, Stanley J, York S, Rosenbaum D, Sarfati D (2018) Risk of lower limb amputation in a national prevalent cohort of patients with diabetes. Diabetologia 61:626–635CrossRef Gurnley JK, Stanley J, York S, Rosenbaum D, Sarfati D (2018) Risk of lower limb amputation in a national prevalent cohort of patients with diabetes. Diabetologia 61:626–635CrossRef
31.
go back to reference Lopéz-Valverde ME, Aragón-Sánchez J, López-de-Andrés A et al (2018) Perioperative and long-term all-cause mortality in patients with diabetes who underwent a lower extremity amputation. Diabetes Res Clin Pract 141:175–180CrossRef Lopéz-Valverde ME, Aragón-Sánchez J, López-de-Andrés A et al (2018) Perioperative and long-term all-cause mortality in patients with diabetes who underwent a lower extremity amputation. Diabetes Res Clin Pract 141:175–180CrossRef
32.
go back to reference Schofield CJ, Libby G, Brennan GM, MacAlpine RR, Morris AD, Leese GP (2006) Mortality and hospitalisation in patients after amputation: a comparison between patients with and without diabetes. Diabetes Care 29:2252–2256CrossRef Schofield CJ, Libby G, Brennan GM, MacAlpine RR, Morris AD, Leese GP (2006) Mortality and hospitalisation in patients after amputation: a comparison between patients with and without diabetes. Diabetes Care 29:2252–2256CrossRef
Metadata
Title
Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study
Authors
Thenmalar Vadiveloo
William Jeffcoate
Peter T. Donnan
Helen C. Colhoun
Stuart McGurnaghan
Sarah Wild
Rory McCrimmon
Graham P. Leese
on behalf of the Scottish Diabetes Research Network Epidemiology Group
Publication date
01-12-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 12/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4723-y

Other articles of this Issue 12/2018

Diabetologia 12/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.